InvestorsObserver
×
News Home

Should Biotechnology Stock Biohaven Pharmaceutical Holding Co Ltd (BHVN) Be in Your Portfolio Friday?

Friday, May 20, 2022 02:26 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Biohaven Pharmaceutical Holding Co Ltd (BHVN) Be in Your Portfolio Friday?

A rating of 84 puts Biohaven Pharmaceutical Holding Co Ltd (BHVN) near the top of the Biotechnology industry according to InvestorsObserver. Biohaven Pharmaceutical Holding Co Ltd's score of 84 means it scores higher than 84% of stocks in the industry. Biohaven Pharmaceutical Holding Co Ltd also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 69 out of the 148 industries.

Overall Score - 63
BHVN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on BHVN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Biohaven Pharmaceutical Holding Co Ltd Stock Today?

Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock has gained 0.4% while the S&P 500 is lower by -1.8% as of 2:25 PM on Friday, May 20. BHVN is higher by $0.56 from the previous closing price of $141.10 on volume of 1,893,416 shares. Over the past year the S&P 500 has fallen -7.90% while BHVN is higher by 87.38%. BHVN lost -$11.85 per share the over the last 12 months. Click Here to get the full Stock Report for Biohaven Pharmaceutical Holding Co Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App